About Bimeda Canada
About Bimeda Canada
Bimeda Canada operations are located in Cambridge, Ontario. Our facilities have been approved to manufacture and distribute FDA, EU, and Canadian regulated products, and offer global logistics capabilities. Bimeda Canada is proud to employ over 170 employees.
Bimeda Canada Headquarters
Cambridge, Ontario
170+
employees
1 manufacturing
facility
We have dedicated customer service, commercial and technical teams that are focused on providing the best products and services possible, to meet our customers’ needs.
Our state-of-the art R&D laboratories contribute to our global R&D program, which is committed to anticipating future needs of the animal health sector.
Customer
Service
Commercial
R&D
Labs
Bimeda Canada Product Range
We offer a comprehensive range of veterinary pharmaceuticals and animal health products for livestock, equine and companion animals. These include nutritional, anti-parasitics, anti-microbials, anti-inflammatories and sedatives.
Learn more about our global locations
Read our corporate brochure to learn more about Bimeda’s global presence
Manufacturing and Distribution
Canada Manufacturing and Distribution
Globally, Bimeda has 9 manufacturing facilities in 8 countries. One of these is located in Cambridge, Ontario.
Manufacturing Capabilities
Manufacturing Capabilities
Address:
420 Beaverdale Road
Cambridge, ON N3C 2W4
Phone: 519-654-8000
Fax: 519-654-8001
Thinking about a career at Bimeda in Cambridge?
Check out our brochure about life in Cambridge.
FDA, Canadian & EU approved – Non-penicillin production facility
Line 2
- Sterile injection production
(plastic – large volume}
Line 3
- Sterile syringe production
(small volume)
Line 4
- Non-sterile syringe production
Line 10
- Sterile injection production (glass)
Syringe Filling
| Batch Size | Fill Size | |
|---|---|---|
| Syringe | 400 - 750 kg | 6 cc – 60 cc |
- Aqueous & non aqueous oral pastes
- Viscosities from 50,000 – 400,000 cps
Sterile Filling Overview
| Batch Size | Fill SIZE | |
|---|---|---|
| Line 2 | 2000 L – 10,000 L | 50 mL - 1000 mL |
| Line 3 | 50 - 400 L | 5, 10, 20, 30, 50 & 100 mL |
- Aqueous & non aqueous solutions
Canada - Manufactured Brands
Our manufacturing facility in Canada produces many well-known and trusted brands, which are used in markets around the world and which play a vital role in optimising the health, welfare and productivity of livestock, as well as promoting the health and wellbeing of horses. From anti-microbial injections, to equine pastes, anti-parasitic injections, injectable NSAIDs and vitamins, popular brands manufactured in Bimeda Canada play a role in optimising the health of animals in North America, Europe and Latin America.
Health & Safety Culture
Bimeda Health and Safety Culture
The health and safety of our employees, contractors and visitors to site is a daily priority in every Bimeda facility.
Our culture of continuous improvement means that Bimeda environmental health and safety management systems are regularly reviewed and optimised; taking into account both industry best practice and input from our Bimeda safety colleagues at our facilities around the world.
Bimeda strives to achieve a goal of:
- ZERO environmental incidents
- ZERO occupational illnesses
- ZERO work-related incidents
To achieve this, we commit to:
- Providing a safe working environment for all Bimeda staff and associates,
- Recognising, respecting and communicating relevant legislation and Bimeda standards to all,
- The reporting, management and continuous reduction of known and suspected risk activities and conditions,
- Supporting the EHS priorities and objectives in all Bimeda facilities globally, and ensuring that Bimeda EHS policy is adhered to by all staff and associates.
We are proud of our sincere and ongoing commitment to optimising health and safety at all Bimeda facilities.
Read the Bimeda Health and Safety Charter in full.
The Bimeda Story
Bimeda – Driving Excellence in Animal Health For 60 Years!
For 60 years, Bimeda colleagues have been driven by a passion for providing science-driven solutions to optimise the health and wellbeing of animals. If your next career move sees you join Bimeda, you’ll be part of a global network of over colleagues who benefit from 6 decades’ of expertise in animal health, and who are committed to working together to find ever-better ways to exceed the expectations of our customers, as we develop new ways to enhance animal health, welfare and productivity.
But how did we get here? Let’s take a walk down memory lane and look at how Bimeda’s unwavering commitment to animal health has seen us grow from a small Irish enterprise, to a leading global player in the animal health industry.
In The Beginning…..
The original premises of Bimeda Chemicals Ltd in Phibsboro, DublinBimeda Chemicals Limited was founded on 22nd April 1960, when a group of Irish veterinary surgeons set up a company to supply Irish veterinarians with quality veterinary products. The original company motto was ‘For And By The Profession’. As the company founders were themselves veterinarians, they had unrivalled knowledge of the needs and wants of their customer base and were able to develop a highly sought product portfolio.
1963 Advertisement from the Journal of The Veterinary Medical Association of IrelandFrom the original premises in Phibsboro, Dublin, Bimeda Chemicals Ltd manufactured a range of veterinary remedies and also distributed a variety of third party products. As the 1963 advertisement from the Journal of The Veterinary Medical Association of Ireland shows, within just a few years Bimeda had a broad and exciting portfolio of products.
Bimeda quickly gained a reputation for both quality and reliability, and successfully drove awareness of the company’s product range through regular, innovative advertising campaigns. Bimeda’s passion for marketing continues to this day and is supported by our global network of marketing colleagues.
1973 - The Bimeda Acquisition and Expansion into the UK
In 1973 Bimeda Chemicals Limited was acquired by the current Irish owners. The family already owned Osmond & Sons (Dublin) Limited and went on to acquire Constant Chemicals Ltd in 1975. These three companies were subsequently brought together in a new location in Tallaght, Dublin. The new Tallaght facility served for many years as a multi-purpose production and warehousing unit; producing injectables, intramammaries, oral solutions, topicals and hygiene products. By this time, Bimeda had also established itself in the UK market, with a distribution base in Liverpool and a reputation for high quality products.
Expansion into Africa
With Bimeda now firmly established in both Ireland and the UK, ambitions moved towards expansion. The export business became a key strategic focus, with the East African market becoming particularly important.
Despite the challenges of both travel and communication at the time, Bimeda thrived; achieving rapid success in East Africa which has been sustained over many decades. Today Bimeda’s AMEA (Africa, Middle East and Asia) business has a physical presence in Kenya, Zambia, Uganda, Tanzania and China, with an export division which serves the entire AMEA region.
The 1990s - Coming To North America
Throughout the late 1980s and early 1990s Bimeda continued to grow, with a strong network of distributor and contract manufacture partners helping Bimeda products to reach veterinarians and farmers all over Europe and Africa.
However, the company had ambitions beyond the European and AMEA regions and in 1991, Bimeda commenced distributing products in the USA. In 1997, an acquisition followed, giving Bimeda its first permanent base in North America. A period of rapid expansion followed, and between 1997 and 2008, Bimeda undertook 5 key acquisitions in the USA, Canada and Mexico, creating a strong R&D, manufacturing and commercial presence throughout the North American continent.
A Decade of Global Acquisitions
2010 marked the start of a new decade and a period of rapid expansion driven by both organic growth and an ambitious acquisition strategy.
Between 2010 and 2019 Bimeda acquired medicinal, nutritional, diagnostics and vaccine businesses in Kenya, Brazil, the UK, US and France, as well as acquiring the veterinary medicine portfolio of Grupo Unipharm in Central America.
-
2011
Acquired
- Assia (Kenya)
- Mogivet (Brazil)
-
2012
Acquired
- Vetpharm Limited
(UK-based exports company)
- Vetpharm Limited
-
2013
Acquired
- Telsol Limited
(UK bolus technology)
- Telsol Limited
-
2014
Acquired
- Zootech (France)
-
2016
Acquired
- ArthroDynamic Technology Inc.
(Equine product specialist, USA) - NBVC (Nutrition, France)
- Iodolab (Diagnostics, France)
- ArthroDynamic Technology Inc.
-
2019
Acquired
- Veterinary Medicine Portfolio of Grupo Unipharm (Central America)
- Texas Vet Lab, Inc (USA)
(Vaccine manufacture and diagnostics)
-
2020
New Identity
- Texas Vet Lab Inc becomes Bimeda Biologicals
-
2021
Acquired
- AquaTactics Fish Health (USA)
-
2022
Acquired
- Afrivet Southern Africa Proprietary Limited (South Africa)
-
2023
Philanthropy
- UCD Bimeda Herd Health Hub & AgTechUCD Innovation Centre
Bimeda philanthropic donation
- UCD Bimeda Herd Health Hub & AgTechUCD Innovation Centre
During this period, Bimeda also joined Rainbow Laboratories Ltd, in establishing a raw material testing and innovation centre in Shijiazhuang, China.
2019 also saw the opening of Bimeda’s Global Innovation Centre in Dublin, Ireland, which leads our global innovation programme, in collaboration with five additional R&D laboratories in Minnesota (USA), Texas (USA), Monet Mor (Brazil), Shiazhuang (China) and Cambridge (Canada).
2020 and Beyond
Bimeda China Shijiazhuang FacilityIn 2020, our state-of-the art sterile injectable manufacturing facility located in Shijiazhuang, China proudly commenced manufacturing operations. The facility is approved to supply quality veterinary pharmaceutical products to China, Australia, New Zealand, Kenya and Uganda.
In 2021, Bimeda was pleased to enter the aquaculture sector, with the acquisition of AquaTactics Fish Health, in the USA. The same year, Bimeda established a new greenfield organisation in Denmark, Bimeda Nordic Aps. From early 2022 Bimeda Nordic commenced supply of our broad range of veterinary pharmaceuticals and animal health products to the Nordic region.
In 2022 Bimeda acquired Afrivet Limited in South Africa, resulting in Bimeda having the largest footprint of any animal health company in Africa.
In 2023 Bimeda made a substantial philanthropic donation to the UCD Foundation in Ireland. This donation was used to help fund the UCD Bimeda Herd Health Hub and AgTechUD Innovation Centre at UCD Lyons Farm in county Kildare, Ireland.
Today Bimeda employs over people worldwide and has a presence in over 80 countries. Our 9 manufacturing and 8 R&D facilities all operate to the highest regulatory standards, and our global supply chain and distribution network sees our products used to enhance animal health in all major food-producing regions.
Bimeda is an organisation which will continue to grow, continue to invest in innovation and continue to be committed to finding ever-better ways to serve our customer, as we continue strive for global excellence in animal health.
If you would like to join us on our exciting journey, check out our current vacancies.
Bimeda Vision, Mission and Values
Vision
To be the partner of choice for optimizing the wellbeing of the world’s animals.
Mission
As a family-owned company with over half a century’s experience in improving global animal health, we are passionate about providing our customers with efficient science-driven solutions to continuously optimise the wellbeing of animals.
Values
To succeed in our mission and vision, we are guided in our work by our Bimeda Values. Through our commitment to our Bimeda Values, we are able to continuously drive our business forward and surpass the expectations of our customers each and every day.
Our 5 Core Values
Customer Focus 
Innovation 
Learning 
Collaboration 
Accountability To learn more about Bimeda’s global presence, why not read our corporate brochure.
Additional Info
- Active Ingredient ivermectin
- Product Tab 1 What is Bimectin Pour-On?
- Product Tab 2 Indications
- Product Tab 3 Benefits
- Product Tab 4 How To Use
- Product Tab 5 Withdrawal Period
- Product Tab 6 Pack Sizes
-
Product Image
- product_website No
- Product Slogan For the control and treatment of common parasites in cattle
- Species Cattle
- Product Category Anti-Parasitic
- Format Liquid
- Rx Drug No
- Legal Category OTC
Careers
Think a career at Bimeda Canada could be right for you?
Learn about life at Bimeda Canada by downloading our ‘Why Bimeda?’ information pack.
Visit our careers website for all current career opportunities, or to submit your CV.
AODA INFORMATION
Should you wish to receive a copy of our AODA policy or Multi Year Accessibility Plan, please visit our accessibility page
I have continued to use Polyglycan® as a standard postoperative parenteral treatment as well for essentially all of my orthopedics.
I have encountered no adverse effects either locally within the joint or any systemic reactions from either route of administration of Polyglycan®.
Robert J. Hunt, DVM, MS, Diplomate
ACVS Hagyard Equine Medical Institute, Lexington, KY
Veterinarian response to a recently published study & article that raised concerns of Polyglycan® safety if adminstered intravenously.
We’ve used over 50,000 mL of Polyglycan® in our practice giving us a high level of comfort and confidence in its applications.
To date there have been no adverse events to be reported by our clients or our practice.
Through my peer group I have not had conversations to suggest that their experience has been different. In my opinion, application of Polyglycan® has benefitted the joint health and the overall well-being of horses that I have had the privilege to be the caregiver.
Chris Morrow, DVM
Mobile Veterinary Practice, Amarillo, TX
Veterinarian response to a recently published study & article that raised concerns of Polyglycan® safety if adminstered intravenously.
the findings of this study do not correlate with what I have seen in 9 years of using this product in a clinical setting, and I disagree with the conclusion that Polyglycan® may be harmful to the joint when administered IV.
Although the experimental model used in this study is the best model available for measuring changes in the joint environment using different medications, in my opinion, the model, as an acute chip fracture, does not replicate the disease process that I see in practice. Hopefully, the findings of this article will lead to new experiments & new discoveries about the processes involved with osteoarthritis.
C.R. Johnson, DVM, MS, DACVS
Equine Surgical Services, Versailles, KY
Veterinarian response to a recently published study & article that raised concerns of Polyglycan® safety if adminstered intravenously.
I have a colt who was feral when I rescued him but progressed wonderfully through his training. When it came time to move him to a new pasture, I was very apprehensive about trailering. He only had one trailering experience in his life, and it was coming to me from where he was captured — it didn’t go well. I heard great things about Confidence EQ® from my veterinary customers who use it in their practices, and I had a sample packet on hand. So, I decided to use it before we trailered him. I am still in shock as to how smoothly things went. My little formerly feral colt walked up and looked at the trailer, alert yet relaxed. He stood there for a moment, and then followed me into the trailer like a seasoned pro! I love that he was tranquil but not tranquilized. He was well aware of what was going on, but comfortable and taking it all in. It was truly a learning experience for him! As a Henry Schein Animal Health representative, I can now wholeheartedly endorse Confidence EQ with a personal experience to back it up!
PAMELA SPATZ, ANIMAL HEALTH DISTRIBUTOR REPRESENTATIVE
Transportation
New Environments